• Healthcare technologies businesses and assets with strong & stable cash flows and long-term patents
  • High growth potential, especially with widened international rollout
  • Key opinion leaders‘ product blessing & durable competitive advantage
  • Product lacked and potentially needed by large healthcare firms but ignored due to currently small distribution size
  • Highly qualified & experienced management with own financial involvement